Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gastric Motility Disorder Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gastric Motility Disorder Drugmarket, defines the market attractiveness level of Gastric Motility Disorder Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gastric Motility Disorder Drug industry, describes the types of Gastric Motility Disorder Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastric Motility Disorder Drug market and the development prospects and opportunities of Gastric Motility Disorder Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastric Motility Disorder Drug market in Chapter 13.
By Player:
Targacept, Inc
Theravance, Inc
Helsinn Healthcare SA
Concert Pharmaceuticals, Inc
ChironWells GmbH
By Type:
Velusetrag
Ipamorelin
TD-8954
Others
By End-User:
Hospital
Clinic
Home Use
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gastric Motility Disorder Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gastric Motility Disorder Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gastric Motility Disorder Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gastric Motility Disorder Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gastric Motility Disorder Drug Market Analysis and Outlook to 2022
-
7.1 Global Gastric Motility Disorder Drug Consumption (2017-2022)
-
7.2 United States Gastric Motility Disorder Drug Consumption (2017-2022)
-
7.3 Europe Gastric Motility Disorder Drug Consumption (2017-2022)
-
7.4 China Gastric Motility Disorder Drug Consumption (2017-2022)
-
7.5 Japan Gastric Motility Disorder Drug Consumption (2017-2022)
-
7.6 India Gastric Motility Disorder Drug Consumption (2017-2022)
-
7.7 South Korea Gastric Motility Disorder Drug Consumption (2017-2022)
8 Region and Country-wise Gastric Motility Disorder Drug Market Analysis and Outlook to 2028
-
8.1 Global Gastric Motility Disorder Drug Consumption Forecast (2022-2028)
-
8.2 United States Gastric Motility Disorder Drug Consumption Forecast (2022-2028)
-
8.3 Europe Gastric Motility Disorder Drug Consumption Forecast (2022-2028)
-
8.4 China Gastric Motility Disorder Drug Consumption Forecast (2022-2028)
-
8.5 Japan Gastric Motility Disorder Drug Consumption Forecast (2022-2028)
-
8.6 India Gastric Motility Disorder Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Gastric Motility Disorder Drug Consumption Forecast (2022-2028)
9 Global Gastric Motility Disorder Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Gastric Motility Disorder Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Velusetrag Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ipamorelin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global TD-8954 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastric Motility Disorder Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Use Consumption and Growth Rate (2017-2022)
10 Global Gastric Motility Disorder Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Gastric Motility Disorder Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Velusetrag Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Ipamorelin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global TD-8954 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gastric Motility Disorder Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Home Use Consumption Forecast and Growth Rate (2022-2028)
11 Global Gastric Motility Disorder Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gastric Motility Disorder Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gastric Motility Disorder Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gastric Motility Disorder Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gastric Motility Disorder Drug Market Competitive Analysis
-
14.1 Targacept, Inc
-
14.1.1 Targacept, Inc Company Details
-
14.1.2 Targacept, Inc Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Targacept, Inc Gastric Motility Disorder Drug Product and Service
-
14.2 Theravance, Inc
-
14.2.1 Theravance, Inc Company Details
-
14.2.2 Theravance, Inc Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Theravance, Inc Gastric Motility Disorder Drug Product and Service
-
14.3 Helsinn Healthcare SA
-
14.3.1 Helsinn Healthcare SA Company Details
-
14.3.2 Helsinn Healthcare SA Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Helsinn Healthcare SA Gastric Motility Disorder Drug Product and Service
-
14.4 Concert Pharmaceuticals, Inc
-
14.4.1 Concert Pharmaceuticals, Inc Company Details
-
14.4.2 Concert Pharmaceuticals, Inc Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Concert Pharmaceuticals, Inc Gastric Motility Disorder Drug Product and Service
-
14.5 ChironWells GmbH
-
14.5.1 ChironWells GmbH Company Details
-
14.5.2 ChironWells GmbH Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 ChironWells GmbH Gastric Motility Disorder Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gastric Motility Disorder Drug
-
Figure Gastric Motility Disorder Drug Picture
-
Table Global Gastric Motility Disorder Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastric Motility Disorder Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastric Motility Disorder Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gastric Motility Disorder Drug Consumption by Country (2017-2022)
-
Figure United States Gastric Motility Disorder Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Gastric Motility Disorder Drug Consumption and Growth Rate (2017-2022)
-
Figure China Gastric Motility Disorder Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastric Motility Disorder Drug Consumption and Growth Rate (2017-2022)
-
Figure India Gastric Motility Disorder Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastric Motility Disorder Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Gastric Motility Disorder Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Gastric Motility Disorder Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastric Motility Disorder Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gastric Motility Disorder Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastric Motility Disorder Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastric Motility Disorder Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastric Motility Disorder Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Velusetrag Consumption and Growth Rate (2017-2022)
-
Figure Global Ipamorelin Consumption and Growth Rate (2017-2022)
-
Figure Global TD-8954 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Home Use Consumption and Growth Rate (2017-2022)
-
Figure Global Velusetrag Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ipamorelin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TD-8954 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Use Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gastric Motility Disorder Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gastric Motility Disorder Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Targacept, Inc (Foundation Year, Company Profile and etc.)
-
Table Targacept, Inc Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Targacept, Inc Gastric Motility Disorder Drug Product and Service
-
Table Theravance, Inc (Foundation Year, Company Profile and etc.)
-
Table Theravance, Inc Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Theravance, Inc Gastric Motility Disorder Drug Product and Service
-
Table Helsinn Healthcare SA (Foundation Year, Company Profile and etc.)
-
Table Helsinn Healthcare SA Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Helsinn Healthcare SA Gastric Motility Disorder Drug Product and Service
-
Table Concert Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Concert Pharmaceuticals, Inc Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Concert Pharmaceuticals, Inc Gastric Motility Disorder Drug Product and Service
-
Table ChironWells GmbH (Foundation Year, Company Profile and etc.)
-
Table ChironWells GmbH Gastric Motility Disorder Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ChironWells GmbH Gastric Motility Disorder Drug Product and Service
-
